OXCARBAZEPINE-D4
OXCARBAZEPINE-D4 Basic information
- Product Name:
- OXCARBAZEPINE-D4
- Synonyms:
-
- OXCARBAZEPINE-D4
- TRILEPTAL-D4
- 10,11-DIHYDRO-10-OXO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE-D4
- 1,2,3,4-tetradeuterio-5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
- 10,11-dihydro-11-oxo-5H-dibenz[b,f]azepine-1,2,3,4-d4-5-carboxamide
- 9-oxo(4,5,6,7-2H?)-2-azatricyclo[9.4.0.03,?]pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide
- D4-Oxcarbazepine
- CAS:
- 1134188-71-8
- MF:
- C15H8D4N2O2
- MW:
- 256.29
- Mol File:
- Mol File
OXCARBAZEPINE-D4 Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- DMSO: soluble
- form
- A solid
OXCARBAZEPINE-D4 Usage And Synthesis
Description
Oxcarbazepine-d4 is intended for use as an internal standard for the quantification of oxcarbazepine by GC- or LC-MS. Oxcarbazepine is a prodrug form of the antiepileptic compound 10,11-dihydro-10-hydroxy carbamazepine . It inhibits high-frequency repetitive firing of rat spinal cord neurons when used at a concentration of 1 μM. Oxcarbazepine protects against electroshock-induced tonic hindlimb extension (ED50s = 10-20 mg/kg), as well as seizures induced by pentylenetetrazole (PTZ; ) or picrotoxin in rodents (ED50s = 23-30 and 150-250 mg/kg, respectively). Formulations containing oxcarbazepine have been used in the treatment of epileptic seizures.
Uses
Oxcarbazepine-d4-1 is deuterium labeled Oxcarbazepine. Oxcarbazepine is a sodium channel blocker[1]. Oxcarbazepine significantly inhibits glioblastoma cell growth and induces apoptosis or G2/M arrest in glioblastoma cell lines[2]. Anti-cancer and anticonvulsant effects[2][3].
References
[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Ashley M Thomas, et al. Old Friends With New Faces: Are Sodium Channel Blockers the Future of Adjunct Pain Medication Management?J Pain. 2018 Jan;19(1):1-9. DOI:10.1016/j.jpain.2017.08.001
[3] Ching-Yi Lee,et al. The effects of antiepileptic drugs on the growth of glioblastoma cell lines. J Neurooncol. 2016 May;127(3):445-53. DOI:10.1007/s11060-016-2056-6
[4] M Schmutz, et al. Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia. 1994;35 Suppl 5:S47-50. DOI:10.1111/j.1528-1157.1994.tb05967.x
OXCARBAZEPINE-D4Supplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 028-67271278 18628360895
- sales@artisbio.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 0755-0755-28967200-8062 13631290199
- wxf@sungening.com
- Tel
- 400-9205774
- sales@glpbio.cn
OXCARBAZEPINE-D4(1134188-71-8)Related Product Information
- Oxcarbazepine N--D-Glucuronide
- 10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide
- 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carbonitrile
- 5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-(1-oxopropoxy)-
- Oxcarbazepine N-Sulfate
- 10-Acetoxy-5H-dibenz[b,f]azepine-5-carboxaMide
- Oxcarbazepine-D4 (Major)
- Oxcarbazepine
- Oclacitinib-13C-d3